3H-1,2,4-Triazol-3-one, 5-[[(2S,3S)-2-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-

3H-1,2,4-Triazol-3-one, 5-[[(2S,3S)-2-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro- Struktur
159706-90-8
CAS-Nr.
159706-90-8
Englisch Name:
3H-1,2,4-Triazol-3-one, 5-[[(2S,3S)-2-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-
Synonyma:
Aprepitant Impurity 71;3H-1,2,4-Triazol-3-one, 5-[[(2S,3S)-2-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-
CBNumber:
CB010526185
Summenformel:
C22H19F7N4O3
Molgewicht:
520.4
MOL-Datei:
159706-90-8.mol

3H-1,2,4-Triazol-3-one, 5-[[(2S,3S)-2-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro- Eigenschaften

Dichte
1.53±0.1 g/cm3(Predicted)
pka
8.06±0.20(Predicted)

Sicherheit

3H-1,2,4-Triazol-3-one, 5-[[(2S,3S)-2-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro- Chemische Eigenschaften,Einsatz,Produktion Methoden

3H-1,2,4-Triazol-3-one, 5-[[(2S,3S)-2-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3H-1,2,4-Triazol-3-one, 5-[[(2S,3S)-2-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
QUALITY CONTROL SOLUTIONS LTD. 13670046396
ORDERS@QCSRM.COM China 18865 58

  • 3H-1,2,4-Triazol-3-one, 5-[[(2S,3S)-2-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-
  • Aprepitant Impurity 71
  • 159706-90-8
  • C22H19F7N4O3
Copyright 2019 © ChemicalBook. All rights reserved